ABEV Financial Statements & Analysis
Complete financial statements for ABEV including income statement, balance sheet, and cash flow statement. Analyze ABEV's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
59
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
12.2% ↑
Net Income
-0.4% ↓
Gross Margin
1.0% ↑
Operating Margin
3.2% ↑
Balance Sheet
Current Ratio
23.0% ↑
Debt to Equity
-21.1% ↑
Asset Turnover
-8.4% ↓
Cash Flow
Operating Cash Flow
5.6% ↑
Net Cash Flow
938.7% ↑
Free Cash Flow
14.1% ↑
Cash Flow to Debt
7.1% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2023 | 2024 | Change | Impact |
---|---|---|---|---|
Revenue | 79.74B | 89.45B | 12.2% | |
Gross Profit | 40.45B | 45.84B | 13.3% | |
Operating Income | 18.83B | 21.80B | 15.8% | |
Net Income | 14.50B | 14.44B | 0.4% | |
EPS | 0.92 | 0.92 | 0.0% | |
EBITDA | 23.46B | 26.72B | 13.9% | |
Gross Margin | 50.72% | 51.24% | 1.0% | |
Operating Margin | 23.62% | 24.37% | 3.2% | |
Net Income Margin | 18.19% | 16.14% | 11.3% | |
R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 89.45B | 79.74B | 79.71B | 72.85B | 58.38B |
Gross Profit | 45.84B | 40.45B | 39.29B | 37.19B | 31.31B |
Operating Income | 21.80B | 18.83B | 17.69B | 17.08B | 15.97B |
Net Income | 14.44B | 14.50B | 14.46B | 12.67B | 11.38B |
EPS | 0.92 | 0.92 | 0.92 | 0.81 | 0.72 |
EBITDA | 26.72B | 23.46B | 23.08B | 22.87B | 20.77B |
Gross Margin | 51.24% | 50.72% | 49.29% | 51.05% | 53.64% |
Operating Margin | 24.37% | 23.62% | 22.19% | 23.44% | 27.36% |
Net Income Margin | 16.14% | 18.19% | 18.14% | 17.39% | 19.49% |
R&D Expenses | 0 | 0 | 0 | 0 | 0 |